Intrebari si raspunsuri Descriere This book offers a comprehensive evaluation of the use of stereotactic body radiosurgery SBRT prostatita congenitala the treatment of prostate cancer. The rationale, selection criteria, and treatment planning for prostate SBRT are explained.
- Este cea mai ieftină metodă terapeutică cu cele mai bune rezultate.
- Adenocarcinomul de prostată - Amethyst Radiotherapy | Centrul de Radioterapie Amethyst
- Oncologie Anul a fost cel mai rău și totodată cel mai bun an.
Important imaging and anatomic considerations are discussed, and detailed consideration devoted to organ motion and tumor tracking during SBRT. Outcomes of therapy are then examined, with thorough appraisal of side effect profiles and quality of life impacts. Clear guidance is provided on how to deliver the therapy in a way that minimizes the risk of long-term urinary and rectal toxicities.
Stereotactic radiosurgery for prostate cancer is an increasingly used form of treatment. Retrospective investigations have demonstrated the safe application of high-dose treatments, with 5-year results comparable to those achieved with protracted external beam radiotherapy.
Prospective studies are underway comparing Radiotherapie prostate with more traditional forms of image-guided and intensity-modulated radiotherapy. In offering in-depth guidance radiotherapie prostate safe delivery of prostate SBRT, this book will be of value for students of radiation oncology, more experienced practitioners, and medical physicists. Textul de pe ultima coperta This book offers a comprehensive evaluation of the use of stereotactic body radiosurgery SBRT for the treatment of prostate cancer.
- Bărbați cu bărbați
- Intrebari si raspunsuri Descriere Treatment strategies in prostate cancer underlie a permanent change due to continuous improvements.
It details key factors that need to be considered to radiotherapie prostate optimal outcomes. Of note, several of these factors, such as optimizing target definition and minimizing organ motion, are pertinent for a broader range of prostate cancer patients and, as such, will appeal to readers seeking a better broad understanding of these topics.
He also serves as a leader of the Genito-urinary Disease Management Team at Memorial Sloan Kettering and has been instrumental in the development of novel radiation techniques that have been adopted worldwide, including IMRT, IGRT, and intraoperative adaptive brachytherapy treatment planning.
Professor Zelefsky has published more than publications as well as chapters and textbooks. He is currently exploring approaches using targeted biologic agents concurrently with hypofractionated stereotactic radiosurgery for high-risk disease as well as the implementation of novel brachytherapy techniques to improve the precision of brachytherapy in the treatment of prostate cancers.
Zelefsky is the Editor in Chief of Brachytherapy, the premier journal in radiotherapie prostate world for articles devoted to the use of brachytherapy in the treatment of cancer.